Thromboxane A 2 synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding

By Kawano K.-i.   Hokamura K.   Kondo K.   Ikeda Y.   Suzuki Y.   Umemura K.  

European Journal of Pharmacology, Vol. 417, Iss. 3, 2001-04 ,pp. : 217-222

Elsevier

Access to resources Recommend Favorite

A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors

By Michaux C.   Dogne J.-M.   Rolin S.   Masereel B.   Wouters J.   Durant F.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 703-710

Elsevier

Access to resources Recommend Favorite

Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3162-3214

Bentham Science Publishers

Access to resources Recommend Favorite

Binding of YM158, a new dual antagonist for leukotriene D 4 and thromboxane A 2 receptors, to guinea pig lung membranes

By Arakida Y.   Ohga K.   Kobayashi S.   Yokota M.   Miyata K.   Yamada T.   Honda K.  

European Journal of Pharmacology, Vol. 362, Iss. 2, 1998-12 ,pp. : 229-233

Elsevier

Access to resources Recommend Favorite

Effect of DP-1904, a thromboxane A 2 synthase inhibitor, on passive Heymann nephritis in rats

By Nagao T.   Nagamatsu T.   Suzuki Y.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite